Blueprint Medicines Corp (BPMC)

May 05, 2025

Blueprint Medicines (NASDAQ:BPMC) Upgraded at StockNews.com - Defense World

May 05, 2025

May 05, 2025

Blueprint Medicines’ (BPMC) Buy Rating Reiterated at HC Wainwright - Defense World

May 05, 2025

May 03, 2025

Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 03, 2025

May 03, 2025

Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025

May 02, 2025

Blueprint Medicines Corp (BPMC) Stock: A Year of Highs and Lows in the Market - investchronicle.com

May 02, 2025

May 02, 2025

BPMC: HC Wainwright & Co. Reiterates Buy Rating on Blueprint Med - GuruFocus

May 02, 2025

May 02, 2025

Blueprint Medicines Corp (BPMC) Performance and Fundamentals Dashboard tells a completely different story - Sete News

May 02, 2025

May 02, 2025

BPMC: HC Wainwright & Co. Reiterates Buy Rating on Blueprint Medicines | BPMC Stock News - GuruFocus

May 02, 2025

May 02, 2025

Blueprint Medicines Corp (BPMC) Q1 2025 Earnings Call Highlights: Strong AYVAKIT Revenue Growth ... - Yahoo Finance

May 02, 2025

May 02, 2025

Blueprint Medicines reports Q1 EPS 1c, consensus (44c) - TipRanks

May 02, 2025

May 02, 2025

Blueprint Medicines Reports Strong Q1 2025 Growth - TipRanks

May 02, 2025

May 01, 2025

Earnings call transcript: Blueprint Medicines Q1 2025 beats EPS, stock rises - Investing.com India

May 01, 2025

May 01, 2025

Blueprint Medicines Corp. Reports Strong Earnings Growth - TipRanks

May 01, 2025

May 01, 2025

Blueprint Medicines (BPMC) Faces Q1 Revenue Miss, Focuses on Str - GuruFocus

May 01, 2025

May 01, 2025

Blueprint Medicines Corp Reports Q1 2025 Earnings: EPS of -$0.56 - GuruFocus

May 01, 2025

May 01, 2025

Blueprint Medicines Corp (NASDAQ: BPMC) Stock Jumping 14.80% Over A Month – Any Room For Its Value To Rise? - Marketing Sentinel

May 01, 2025

May 01, 2025

Predicting Blueprint Medicines Corp’s (BPMC) earnings for the current quarter - uspostnews.com

May 01, 2025

May 01, 2025

Blueprint Medicines Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 01, 2025

May 01, 2025

Blueprint Medicines Q1 2025 slides: AYVAKIT revenue surges 61%, guidance raised - Investing.com India

May 01, 2025

May 01, 2025

Blueprint Medicines: Q1 Earnings Snapshot - marketscreener.com

May 01, 2025

May 01, 2025

Blueprint Medicines Corp earnings beat by $0.50, revenue fell short of estimates - Investing.com

May 01, 2025

May 01, 2025

Blueprint Medicines Reports First Quarter 2025 Results - TradingView

May 01, 2025

May 01, 2025

Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance - PR Newswire

May 01, 2025

Apr 30, 2025

Blueprint Medicines patents new EGFR mutant inhibitors for NSCLC - BioWorld MedTech

Apr 30, 2025

Apr 29, 2025

Blueprint Medicines (NASDAQ:BPMC) Price Target Cut to $130.00 by Analysts at Needham & Company LLC - Defense World

Apr 29, 2025

Apr 28, 2025

Needham Adjusts Price Target for Blueprint Medicines (BPMC) Ahea - GuruFocus

Apr 28, 2025

Apr 28, 2025

What Analysts Are Saying About Blueprint Medicines Stock - Benzinga

Apr 28, 2025

Apr 28, 2025

Blueprint Medicines stock target cut to $130 at Needham - Investing.com

Apr 28, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Envestnet Asset Management Inc. Buys 3,723 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Apr 26, 2025

Apr 25, 2025

Blueprint Medicines Announces Q1 2025 Earnings Date: Key Biotech Updates Coming May 1 - Stock Titan

Apr 25, 2025

Apr 24, 2025

Blueprint Medicines Corp (BPMC) is looking forward to a strong quarter - Sete News

Apr 24, 2025

Apr 24, 2025

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Blueprint Medicines (BPMC) to Release Earnings on Thursday - Defense World

Apr 24, 2025

Apr 23, 2025

Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying - Insider Monkey

Apr 23, 2025

Apr 23, 2025

Wells Fargo & Company MN Cuts Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Apr 23, 2025

Apr 23, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by LPL Financial LLC - Defense World

Apr 23, 2025

Apr 21, 2025

BPMC stock rated an Equal-weight by Morgan Stanley - knoxdaily.com

Apr 21, 2025

Apr 19, 2025

Wedbush Decreases Earnings Estimates for Blueprint Medicines - Defense World

Apr 19, 2025

Apr 18, 2025

What is Wedbush’s Forecast for BPMC Q3 Earnings? - Defense World

Apr 18, 2025

Apr 18, 2025

Wedbush Reaffirms “Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC) - Defense World

Apr 18, 2025

Apr 17, 2025

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC) - The Globe and Mail

Apr 17, 2025

Apr 15, 2025

Blueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 15, 2025

Apr 13, 2025

Franklin Resources Inc. Lowers Stake in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Apr 13, 2025

Apr 13, 2025

O Shaughnessy Asset Management LLC Reduces Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Apr 13, 2025

Apr 11, 2025

Blueprint Medicines Corp (BPMC) Shares Plummet Below 1-Year High - News Heater

Apr 11, 2025

Apr 09, 2025

Blueprint Medicines’ (BPMC) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World

Apr 09, 2025

Apr 08, 2025

Breaking Down Blueprint Medicines: 14 Analysts Share Their Views - Benzinga

Apr 08, 2025

Apr 07, 2025

Blueprint Medicines at Needham Conference: Strategic Growth in Mastocytosis - Investing.com

Apr 07, 2025

Apr 07, 2025

Blueprint Medicines Corp [BPMC] stock was sold by Haviland Kate at the price of US$0.22 million - knoxdaily.com

Apr 07, 2025

Apr 04, 2025

Blueprint Medicines stock hits 52-week low at $80.64 - Investing.com

Apr 04, 2025